Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study
NCT04384614 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2020-08-27
Summary
Covid-19 In Tunisia: AN Observational Cross-Sectional Registry Study
Conditions
- Covid 19
- BCG Vaccination
Interventions
- DIAGNOSTIC_TEST
-
Test PCR
Viral load (COVID+) testing by PCR
- GENETIC
-
TDR
IDR and blood sampling for testing DNA Cheque
- OTHER
-
Clinical Examination
COVID 19 symptoms and Physical Examination
Sponsors & Collaborators
-
Eshmoun Clinical Research Center
collaborator NETWORK -
Dacima Consulting
collaborator OTHER -
Direction des Soins de Santé de Base
lead OTHER_GOV
Principal Investigators
-
Agnès Hamzaoui, Pr · Hopital Abderrahmane Mami
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-15
- Primary Completion
- 2020-07-15
- Completion
- 2020-07-15
Countries
- Tunisia
Study Locations
More Related Trials
-
EUpertstrain 4 Study of Bordetella Pertussis Isolates
NCT03197597 ·Status: COMPLETED
-
Bordetella Pertussis Colonisation Challenge Study
NCT03751514 ·Status: UNKNOWN ·Phase: NA
-
Monitoring COVID-19 Vaccination Response in Fragile Populations
NCT05222139 ·Status: COMPLETED
-
Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)
NCT05085522 ·Status: UNKNOWN
-
Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
NCT01138956 ·Status: UNKNOWN ·Phase: NA
-
Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks
NCT05847322 ·Status: RECRUITING ·Phase: NA
-
Leukapheresis Sampling for Immune Responses After BCG Vaccination in BCG-naïve Healthy Adults in the US
NCT02413502 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Complex Cutaneous Leishmaniasis Healing Study in Algeria
NCT03292835 ·Status: TERMINATED
-
Assessment of Pharyngeal Carriage of Microorganisms Responsible for Transmissible Acute Respiratory Infections in HAJJ Pilgrims.
NCT02868541 ·Status: COMPLETED
-
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers
NCT04659941 ·Status: UNKNOWN ·Phase: PHASE2
-
Genetic Diversity of Toxoplasma Gondii in Cancer Patients
NCT04834076 ·Status: UNKNOWN
-
Evaluation of Point-of-care Tests for the Diagnosis of Cutaneous Leishmaniasis in Afghanistan
NCT03435419 ·Status: COMPLETED
-
Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.
NCT04345315 ·Status: UNKNOWN
-
TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
NCT00523926 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis
NCT02845934 ·Status: COMPLETED ·Phase: NA
-
Cutaneous Diphtheria in France : Observational, Retrospective Study of Patient Characteristics
NCT05798247 ·Status: COMPLETED
-
COVID-19 STAndard of Care in Sub-Saharan Africa
NCT04885543 ·Status: COMPLETED
-
Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC
NCT04235361 ·Status: UNKNOWN
-
OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 "
NCT04584567 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland
NCT04648800 ·Status: UNKNOWN ·Phase: PHASE3
-
Development and Validation of (Bio)Sensors for the Identification of Pathogens
NCT06548841 ·Status: COMPLETED
-
A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis
NCT02684240 ·Status: COMPLETED ·Phase: PHASE2
-
Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine
NCT04328441 ·Status: COMPLETED ·Phase: PHASE3
-
Nasal Swab Study to Explore the Nasal Microbia
NCT02535442 ·Status: COMPLETED
-
Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region
NCT07017803 ·Status: NOT_YET_RECRUITING